Atypical inflammatory demyelinating syndromes of the CNS

Todd A. Hardy, Stephen W. Reddel, Michael H. Barnett, Jacqueline Palace, Claudia F Lucchinetti, Brian G Weinshenker

Research output: Contribution to journalReview article

31 Citations (Scopus)

Abstract

Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for multiple sclerosis. These syndromes include neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis, tumefactive demyelination, Baló's concentric sclerosis, Schilder's disease, and Marburg's multiple sclerosis. The overlapping features of these syndromes with multiple sclerosis and with each other complicate diagnosis and their categorisation as distinct or related conditions. Recognition of these syndromes is crucial because they differ from multiple sclerosis and other demyelinating and non-demyelinating conditions in their prognosis and treatment. Advances in MRI, pathology, and immunobiology are needed to increase understanding of these syndromes, including the extent to which some of them represent distinct entities, and to assist with improvements in their diagnosis and management.

Original languageEnglish (US)
Pages (from-to)967-981
Number of pages15
JournalThe Lancet Neurology
Volume15
Issue number9
DOIs
StatePublished - Aug 1 2016

Fingerprint

Multiple Sclerosis
Diffuse Cerebral Sclerosis of Schilder
Acute Disseminated Encephalomyelitis
Neuromyelitis Optica
Demyelinating Diseases
Sclerosis
Pathology
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Atypical inflammatory demyelinating syndromes of the CNS. / Hardy, Todd A.; Reddel, Stephen W.; Barnett, Michael H.; Palace, Jacqueline; Lucchinetti, Claudia F; Weinshenker, Brian G.

In: The Lancet Neurology, Vol. 15, No. 9, 01.08.2016, p. 967-981.

Research output: Contribution to journalReview article

Hardy, Todd A. ; Reddel, Stephen W. ; Barnett, Michael H. ; Palace, Jacqueline ; Lucchinetti, Claudia F ; Weinshenker, Brian G. / Atypical inflammatory demyelinating syndromes of the CNS. In: The Lancet Neurology. 2016 ; Vol. 15, No. 9. pp. 967-981.
@article{0426ccbdb073477e9dc0f162a72665df,
title = "Atypical inflammatory demyelinating syndromes of the CNS",
abstract = "Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for multiple sclerosis. These syndromes include neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis, tumefactive demyelination, Bal{\'o}'s concentric sclerosis, Schilder's disease, and Marburg's multiple sclerosis. The overlapping features of these syndromes with multiple sclerosis and with each other complicate diagnosis and their categorisation as distinct or related conditions. Recognition of these syndromes is crucial because they differ from multiple sclerosis and other demyelinating and non-demyelinating conditions in their prognosis and treatment. Advances in MRI, pathology, and immunobiology are needed to increase understanding of these syndromes, including the extent to which some of them represent distinct entities, and to assist with improvements in their diagnosis and management.",
author = "Hardy, {Todd A.} and Reddel, {Stephen W.} and Barnett, {Michael H.} and Jacqueline Palace and Lucchinetti, {Claudia F} and Weinshenker, {Brian G}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/S1474-4422(16)30043-6",
language = "English (US)",
volume = "15",
pages = "967--981",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "9",

}

TY - JOUR

T1 - Atypical inflammatory demyelinating syndromes of the CNS

AU - Hardy, Todd A.

AU - Reddel, Stephen W.

AU - Barnett, Michael H.

AU - Palace, Jacqueline

AU - Lucchinetti, Claudia F

AU - Weinshenker, Brian G

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for multiple sclerosis. These syndromes include neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis, tumefactive demyelination, Baló's concentric sclerosis, Schilder's disease, and Marburg's multiple sclerosis. The overlapping features of these syndromes with multiple sclerosis and with each other complicate diagnosis and their categorisation as distinct or related conditions. Recognition of these syndromes is crucial because they differ from multiple sclerosis and other demyelinating and non-demyelinating conditions in their prognosis and treatment. Advances in MRI, pathology, and immunobiology are needed to increase understanding of these syndromes, including the extent to which some of them represent distinct entities, and to assist with improvements in their diagnosis and management.

AB - Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for multiple sclerosis. These syndromes include neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis, tumefactive demyelination, Baló's concentric sclerosis, Schilder's disease, and Marburg's multiple sclerosis. The overlapping features of these syndromes with multiple sclerosis and with each other complicate diagnosis and their categorisation as distinct or related conditions. Recognition of these syndromes is crucial because they differ from multiple sclerosis and other demyelinating and non-demyelinating conditions in their prognosis and treatment. Advances in MRI, pathology, and immunobiology are needed to increase understanding of these syndromes, including the extent to which some of them represent distinct entities, and to assist with improvements in their diagnosis and management.

UR - http://www.scopus.com/inward/record.url?scp=84992184044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992184044&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(16)30043-6

DO - 10.1016/S1474-4422(16)30043-6

M3 - Review article

VL - 15

SP - 967

EP - 981

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 9

ER -